ERIBA
ERIBA (European Research Institute for the Biology of Ageing) is a leading research institute dedicated to understanding the biological mechanisms of ageing. The institute is located in Groningen, Netherlands, and is affiliated with the University of Groningen and the University Medical Center Groningen.
History[edit | edit source]
ERIBA was established in 2013 with the aim of improving our understanding of the biological mechanisms of ageing. The institute was founded by the University of Groningen and the University Medical Center Groningen, with support from the European Union.
Research[edit | edit source]
ERIBA conducts research in various areas related to the biology of ageing. The institute's research is organized into several research groups, each focusing on a specific aspect of ageing biology. These include the Cellular Senescence group, the Genome Structure and Ageing group, and the Stem Cells and Ageing group.
The Cellular Senescence group studies the role of cellular senescence in ageing and age-related diseases. The Genome Structure and Ageing group investigates the changes in genome structure that occur during ageing and how these changes contribute to age-related diseases. The Stem Cells and Ageing group explores the role of stem cells in ageing and the development of age-related diseases.
Facilities[edit | edit source]
ERIBA is housed in a state-of-the-art research facility that includes laboratories, offices, and meeting rooms. The institute also has access to the extensive research facilities of the University of Groningen and the University Medical Center Groningen.
Collaboration[edit | edit source]
ERIBA collaborates with other research institutions and organizations around the world. These collaborations aim to advance our understanding of the biology of ageing and to develop new treatments for age-related diseases.
See also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
